Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Lion Biotechnologies- Inc. (LBIO)

6.95 -0.20 (-2.80%)

6/27/2017  4:00pm

Open:

N/A

Pre. Close:

7.15

High:

N/A

Low:

N/A

Volume:

0

Market Cap:

N/A

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.79 - 6.21

6.21 - 6.63

Low:

5.11 - 5.19

5.19 - 5.28

Close:

5.26 - 5.68

5.68 - 6.1

Technical analysis  (as of: 2017-09-08 4:44:53 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 7.47     One year: 8.29

Support:

Support1: 5.25    Support2: 4.37

Resistance:

Resistance1: 6.39    Resistance2: 7.10

Pivot:

5.78

Moving Averages:

MA(5): 5.54     MA(20): 5.92

MA(100): 6.40     MA(250): 6.98

MACD:

MACD(12,26): -0.28     Signal(12,26,9): -0.24

%K %D:

%K(14,3): 13.15     %D(3): 16.33

RSI:

RSI(14): 31.71

52-Week:

High: 8.60  Low: 4.45  Change(%): -40.9

Average Vol(K):

3-Month: 36327  10-Days 19276

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
LBIO has closed above bottom band by 15.7%. Bollinger Bands are 9.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 20 Sep 2017 22:07:30 GMT
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $50 ...

Tue, 27 Jun 2017 12:00:00 GMT
Lion Biotechnologies, Inc. Changes Name to Iovance Biotherapeutics, Inc.

Sat, 01 Jul 2017 12:44:58 GMT
6.90

Mon, 03 Jul 2017 12:29:20 GMT
What Lies Ahead For Lion Biotechnogolies?

Mon, 11 Sep 2017 12:00:00 GMT
Iovance Biotherapeutics Partners with TrakCel for Personalized Patient Product ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Diagnostics Testing

Shares Out. (M)

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-1.980

EPS Est. Current Year

-1.350

EPS Est. Next Year

-1.380

EPS Est. Next Quarter

-0.340

Forward EPS

1.#IO

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.915

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-2.70

P/E Growth Ratio

-0.03

P/BV

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-09-26

Last Split Ratio

0.01

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.